• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肌萎缩侧索硬化症日本版评估问卷40(ALSAQ - 40)的有效性及临床适用性]

[Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].

作者信息

Yamaguchi Takuhiro, Ohbu Sadayoshi, Saito Mari, Ito Yoichi, Moriwaka Fumio, Tashiro Kunio, Ohashi Yasuo, Fukuhara Shun-ichi

机构信息

Department of Biostatisitcs, School of Health Sciences and Nursing, University of Tokyo.

出版信息

No To Shinkei. 2004 Jun;56(6):483-94.

PMID:15328837
Abstract

We studied validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis (ALS) assessment questionnaire 40 (ALSAQ-40). The original version contains forty questions measuring five areas (domains) of health status: Physical Mobility, ADL/Independence, Eating and Drinking, Communication and Emotional Functioning. Data were obtained from 39 ALS patients and from their physicians at 15 centers in Japan. Patients completed the ALSAQ-40 and the SF-36, and provided information on their age and their status of ventilator use. Their physicians provided information on the date of diagnosis, type of disease and clinical characteristics, and ALSFRS-R. The patients' average age was 58.5 years, and 64% were men. The mean duration since diagnosis was 39.1 months. Forty four percent were classical ALS patients and 46% were receiving a respiratory intervention. Although there was much heterogeneity, the scores for Physical Mobility and ADL/Independence were higher(indicating worse health status)than the scores for the other domains. Item-scale correlations were strong, except for the item "felt embarrassed in social situations" in the Emotional Functioning domain. All the domains had very high internal consistency: Cronbach's alphas ranged 0.95 to 0.97. With regard to the cluster structure of the forty items, the Eating and Drinking domain and the Communication clustered together. The reason might be that the former consisted of only three items and both domains measure bulbar symptoms. Domain scores correlated significantly with scores of related dimensions in the SF-36 and ALSFRS-R, and did not correlate strongly with unrelated domains. The five items of the ALSAQ-5 correlated with all five domain scores on the ALSAQ-40. These results should be interpreted with caution because we analyzed together data from ALS patients with various characteristics. In conclusion, although we may need to add and remove some items and modify the wording of others, the Japanese version of the ALSAQ-40 had high validity and is likely to be useful in evaluating of QOL in ALS patients. Whether the ALSAQ-5 can be used in place of the ALSAQ-40 is a matter for further study.

摘要

我们研究了肌萎缩侧索硬化症(ALS)评估问卷40(ALSAQ - 40)日文版的有效性和临床适用性。原始版本包含40个问题,用于测量健康状况的五个领域(维度):身体活动能力、日常生活活动/独立性、饮食、沟通和情绪功能。数据来自日本15个中心的39例ALS患者及其医生。患者完成了ALSAQ - 40和SF - 36,并提供了他们的年龄和使用呼吸机情况的信息。他们的医生提供了诊断日期、疾病类型和临床特征以及ALSFRS - R的信息。患者的平均年龄为58.5岁,64%为男性。自诊断以来的平均病程为39.1个月。44%为经典型ALS患者,46%正在接受呼吸干预。尽管存在很大的异质性,但身体活动能力和日常生活活动/独立性领域的得分(表明健康状况较差)高于其他领域的得分。除了情绪功能领域中“在社交场合感到尴尬”这一项目外,各项目与量表的相关性都很强。所有领域都具有非常高的内部一致性:Cronbach's α系数范围为0.95至0.97。关于40个项目的聚类结构,饮食领域和沟通领域聚集在一起。原因可能是前者仅由三个项目组成,且两个领域都测量延髓症状。领域得分与SF - 36和ALSFRS - R中相关维度得分显著相关,与不相关领域没有强相关性。ALSAQ - 5中的五个项目与ALSAQ - 40上的所有五个领域得分相关。由于我们一起分析了具有各种特征的ALS患者的数据,这些结果应谨慎解释。总之,尽管我们可能需要添加和删除一些项目并修改其他项目的措辞,但ALSAQ - 40日文版具有较高的有效性,并且可能有助于评估ALS患者的生活质量。ALSAQ - 5是否可以替代ALSAQ - 40有待进一步研究。

相似文献

1
[Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].[肌萎缩侧索硬化症日本版评估问卷40(ALSAQ - 40)的有效性及临床适用性]
No To Shinkei. 2004 Jun;56(6):483-94.
2
Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5.荷兰版肌萎缩侧索硬化症评估问卷(ALSAQ - 40、ALSAQ - 5)的效度
Amyotroph Lateral Scler. 2007 Apr;8(2):96-100. doi: 10.1080/17482960601012541.
3
Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.肌萎缩侧索硬化症患者问卷ALSAQ - 40的西班牙语改编版。
Amyotroph Lateral Scler. 2008 Jun;9(3):168-72. doi: 10.1080/17482960801934072.
4
Comparison of the 40-item Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) with a short-form five-item version (ALSAQ-5) in a longitudinal survey.在一项纵向调查中,对40项肌萎缩侧索硬化症评估问卷(ALSAQ - 40)与简短的五项版本(ALSAQ - 5)进行比较。
Clin Rehabil. 2007 Mar;21(3):266-72. doi: 10.1177/0269215506071123.
5
Spanish adaptation of the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R).修订版肌萎缩侧索硬化功能评定量表(ALSFRS-R)的西班牙语改编版。
Amyotroph Lateral Scler. 2010 Oct;11(5):475-7. doi: 10.3109/17482968.2010.489115.
6
[Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].肌萎缩侧索硬化功能评定量表的研究:修订版肌萎缩侧索硬化功能评定量表(ALSFRS-R)日语版
No To Shinkei. 2001 Apr;53(4):346-55.
7
[Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study].[使用肌萎缩侧索硬化功能评定量表修订版(日语版)开发肌萎缩侧索硬化患者电话调查系统及其在纵向多中心研究中的应用]
Brain Nerve. 2011 May;63(5):491-6.
8
The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.肌萎缩侧索硬化功能评定量表。肌萎缩侧索硬化患者日常生活活动能力评估。肌萎缩侧索硬化睫状神经营养因子治疗研究(ACTS)I-II期研究组。
Arch Neurol. 1996 Feb;53(2):141-7.
9
Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40.肌萎缩侧索硬化症/运动神经元病患者健康状况简短测量方法的开发与验证:ALSAQ-40量表。
J Neurol. 1999 Nov;246 Suppl 3:III16-21. doi: 10.1007/BF03161085.
10
Validation of quality of life instruments in ALS.肌萎缩侧索硬化症生活质量评估工具的验证
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Mar;5(1):55-60. doi: 10.1080/14660820310016066.

引用本文的文献

1
Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials.醋酸亮丙瑞林治疗脊髓性肌萎缩症和延髓性肌肉萎缩症受试者的疗效和安全性:两项随机对照试验的汇总分析。
J Neurol. 2019 May;266(5):1211-1221. doi: 10.1007/s00415-019-09251-x. Epub 2019 Mar 7.
2
Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients.依达拉奉(MCI-186)治疗肌萎缩侧索硬化症患者疗效与安全性的验证性双盲、平行组、安慰剂对照研究。
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):610-7. doi: 10.3109/21678421.2014.959024. Epub 2014 Oct 6.
3
Self perceived emotional functioning of spanish patients with amyotrophic lateral sclerosis: a longitudinal study.
西班牙肌萎缩侧索硬化症患者的自我感知情绪功能:一项纵向研究。
Front Psychol. 2013 Jan 8;3:609. doi: 10.3389/fpsyg.2012.00609. eCollection 2012.
4
Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy.未治疗和安慰剂治疗的脊髓性肌萎缩症和延髓性肌萎缩症患者结局测量指标的时间变化差异。
J Neurol. 2012 Apr;259(4):712-9. doi: 10.1007/s00415-011-6251-2. Epub 2011 Sep 28.
5
Impact and characteristics of quality of life in Japanese patients with multiple sclerosis.多发性硬化症日本患者的生活质量影响及其特征。
Qual Life Res. 2011 Feb;20(1):119-31. doi: 10.1007/s11136-010-9725-2. Epub 2010 Aug 11.